UPDATE : Friday, October 20, 2017
상단여백
HOME Pharma
Rethink obesity, says Novo Nordisk Korea
  • By Marian Chu
  • Approval 2017.10.12 11:20
  • comments 0

Obesity should no longer be seen as the result of individuals’ habits but recognized as a chronic illness, Novo Nordisk Korea said Thursday.

Novo Nordisk employees hold their Korean slogans for the company’s “Rethink Obesity” campaign Tuesday.

The Korean offshoot of the Danish pharmaceutical giant hosted an in-house contest Tuesday to come up with a Korean name for its “Rethink Obesity” campaign, to raise awareness of obesity as a chronic disease. The first prize went to “Biman Jaego,” a literal translation of Rethink Obesity.

Rethink Obesity is a global campaign aimed at medical professionals seeking to rectify the social perception of obesity and the importance of obesity management, the company said.

“Obesity is not just a problem of individual laziness or overeating. We need to raise awareness of obesity as a chronic illness stemming from various elements,” said Rana Azfar Zafar, the general manager of the Korean branch.

“Novo Nordisk Korea, with the recent approval of the world’s first GLP-1 obesity treatment Saxenda, will continue to provide the correct information and education of obesity to domestic health care providers and the obese so they can lead a healthy life,” the official added.

Since 2015, 50 countries have observed October 11 as World Obesity Day holding a variety of activities to prevent, reduce, and treat obesity, the company said.

yjc@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
Comments 0
More
Please leave the first comment.
여백
여백
여백
Back to Top